Using two tools to identify Potentially Inappropriate Medications (PIM) in elderly patients in Southern Chile

被引:10
作者
Arellano, Camila [1 ]
Saldivia, Gabriela [2 ]
Cordova, Pia [3 ]
Fernandez, Pola [3 ]
Morales, Felipe [1 ]
Lopez, Mariela [1 ]
Villa, Lorenzo [1 ]
机构
[1] Univ Concepcion, Fac Farm, Dept Farm, Concepcion, Chile
[2] Hosp Las Higueras, Chief Pharm Unit, Talcahuano, Chile
[3] Univ Concepcion, Fac Farm, Dept Farm, Hosp Las Higueras, Concepcion, Chile
关键词
Potentially inappropriate medications; Elderly; Polypharmacy; Comorbidities; EXCESSIVE POLYPHARMACY; PRIMARY-CARE; HOSPITALIZATION; VALIDATION; CRITERIA; PEOPLE; BEERS;
D O I
10.1016/j.archger.2016.08.001
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: To assess and compare the prevalence of prescribing of potentially inappropriate medications (PIMs) identified using the Beers and STOPP criteria; and to determine the clinical variables related with the prescription of PIMs in older adults. Methods: An observational study of 250 patients aged 65 years or older was conducted in a large teaching hospital. Beers (2012) and STOPP (2008) criteria were utilized to identify PIMs. Data on age, sex, admission and discharge dates, diagnoses, and medications prescribed were obtained from medical records. Multivariate logistic regression was used to determine patient variables related with the prescription of PIMs. Key findings: Using Beers criteria, 375 PIMs were identified in 198 patients. 32% of these patients were prescribed one PIM, 20% were prescribed two PIMs, and 48% were prescribed more than two PIMs. Using STOPP criteria, 148 PIMs were identified in 120 patients. 41% of these patients were prescribed one PIM, 51% were prescribed two PIMs, and 8% were prescribed more than two PIMs. An association between PIM prescribing and polypharmacy was detected with both criteria. After adjusting for confounding variables, the prescription of Beers-identified PIMs was significantly associated with patients older than 80 (OR: 2.99; 95% CI: 1.13-7.89) and with length of hospital stay of more than 15 days (OR: 2.78; 95% CI: 1.20-6.44). Conclusion: These two criteria showed that the prescription of PIMs is prevalent in hospitalized elderly patients. It may be beneficial to educate healthcare teams about these criteria to reduce the prescription of PIMs. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:139 / 144
页数:6
相关论文
共 26 条
[11]   Healthcare outcomes associated with Beers' criteria: A systematic review [J].
Jano, Elda ;
Aparasu, Rajender R. .
ANNALS OF PHARMACOTHERAPY, 2007, 41 (03) :438-448
[12]  
Lim SC, 2006, ANN ACAD MED SINGAP, V35, P27
[13]  
Liu Gordon G, 2002, J Am Pharm Assoc (Wash), V42, P847
[14]   Inappropriate Prescribing Predicts Adverse Drug Events in Older Adults [J].
Lund, Brian C. ;
Carnahan, Ryan M. ;
Egge, Jason A. ;
Chrischilles, Elizabeth A. ;
Kaboli, Peter J. .
ANNALS OF PHARMACOTHERAPY, 2010, 44 (06) :957-963
[15]  
Ministerio de Salud de Costa Rica, 2001, ENCUESTA NACL CONSUM
[16]   A comparison of the Beers and STOPP criteria for identifying the use of potentially inappropriate medications among elderly patients in primary care [J].
Oliveira, Marcio Galvao ;
Amorim, Welma Wildes ;
de Jesus, Sandra Rego ;
Heine, Jacqueline Miranda ;
Coqueiro, Herica Lima ;
Santana Passos, Luiz Carlos .
JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2015, 21 (02) :320-325
[17]  
Page RL, 2010, CLIN INTERV AGING, V5, P75
[18]   Interventions to improve the appropriate use of polypharmacy for older people [J].
Patterson, Susan M. ;
Hughes, Carmel ;
Kerse, Ngaire ;
Cardwell, Chris R. ;
Bradley, Marie C. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (05)
[19]   Potentially inappropriate prescriptions for older patients in long-term care [J].
Rancourt C. ;
Moisan J. ;
Baillargeon L. ;
Verreault R. ;
Laurin D. ;
Grégoire J.-P. .
BMC Geriatrics, 4 (1)
[20]   Potentially inappropriate prescribing in an Irish elderly population in primary care [J].
Ryan, Cristin ;
O'Mahony, Denis ;
Kennedy, Julia ;
Weedle, Peter ;
Byrne, Stephen .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (06) :936-947